Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Vardenafil tablet bulk supplier for pharma manufacturers

Vardenafil Tablet 5 mg, 10 mg, 20 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 5 mg, 10 mg, 20 mg

Reference Brands: Levitra, Staxyn(US & EU)

Category: Sexual Wellness

Vardenafil inhibits phosphodiesterase type 5 (PDE5), increasing nitric oxide effects and blood flow to the penis. It enhances erectile function, with benefits including rapid onset, a long duration (up to 4-6 hours), improved sexual performance, and increased confidence, supporting effective treatment of erectile dysfunction.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Vardenafil tablets, marketed as Levitra and Staxyn, are approved in the US by the FDA and in the EU via EMA for erectile dysfunction. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and quality data, while the EMA ensures compliance with regional safety standards. 

Vardenafil Tablet — third party manufacturing & bulk supply

Vardenafil Tablet 5 mg, 10 mg, 20 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Vardenafil Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Vardenafil Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Vardenafil Tablet →
Back to Listing

Frequently Asked Questions

Vardenafil tablet is listed as Tablet in 5 mg, 10 mg, 20 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Vardenafil tablet is referenced against Levitra, Staxyn(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Tadalafil Tablets

Strength:
2.5 mg, 5 mg, 10 mg, 20 mg and 40 mg(P. Hypertension)

Form: Tablet

Reference Brands: Cialis(US & EU),Adcirca(US)

View Details
Avanafil Tablets

Strength:
50 mg, 100 mg, 200 mg

Form: Tablet

Reference Brands: Stendra(US)

View Details
Sildenafil Citrate Tablets

Strength:
25 mg, 50 mg, 100 mg; For pulmonary: 20 mg, 40 mg, 60 mg, 80 mg

Form: Tablet

Reference Brands: (US & EU): Viagra, Revatio (for pulmonary hypertension)

View Details
Alprostadil Injection

Strength:
10 µg and 20 µg

Form: Injection

Reference Brands: Caverject, Edex(US)

View Details
Ginseng Capsules

Strength:
100–200 mg

Form: capsules

Reference Brands: Nature’s Way Ginseng, NOW Foods Ginseng(US)

View Details
Ashwagandha Capsules

Strength:
300-600 mg

Form: Capsules

Reference Brands: NOW Foods Ashwagandha

View Details
Horny Goat Weed Capsules

Strength:
500–700 mg

Form: Capsules

Reference Brands: NOW Foods Horny Goat Weed(US)

View Details
Tribulus Terrestris Capsules

Strength:
500-750 mg

Form: Capsules

Reference Brands: Optimum Nutrition Tribulus(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.